Cramer’s lightning round: Hims & Hers Health is not a buy
Loading chart…
Hims & Hers Health Inc: “Hims & Hers lose money … I’m not recommending stocks that are losing a lot of money.”
Loading chart…
Two Harbors Investment Corp: “I’m not going there. We’ve seen a lot of companies like that. … I’m not playing.”
Loading chart…
Shell Midstream Partners LP: “[Enterprise Product Partners], that’s the best one if you want to be in that group now.”
Loading chart…
Healthcare Realty Trust Inc: “I thought [the company’s merger with Healthcare Trust of America] made a lot of sense. … I like it.”
Loading chart…
DraftKings Inc: “[Kynikos Associates founder] Jim Chanos says it’s a great short. I think the time to short the stock was much, much higher.”
Loading chart…
Gilead Sciences Inc: “I know it looks very, very cheap. But you know what, that’s not why we buy drugs stocks. We buy drug stocks because they’ve got growth, and Gilead has none.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com
- The Benefits of Meal Prepping for Busy Moms - October 28, 2023
- The 11 Best Cash ETFs in Canada (Plus HISA ETFs and Money Market ETFs) - October 8, 2023
- Build a Variety of Outfits with These 7 Affordable Pieces - October 7, 2023